McDonald’s Quarter Pounder pulled amid E. Coli outbreak
It seems like McDonald’s is in the frying pan again—this time, not for their burgers but for what’s possibly lurking in them. Late last week, [more…]
It seems like McDonald’s is in the frying pan again—this time, not for their burgers but for what’s possibly lurking in them. Late last week, [more…]
Novo Nordisk’s weight-loss drug Wegovy has received the green light in China, targeting the world’s second-largest economy and the country with the highest number of [more…]
Celltrion, the pioneering Korean biopharmaceuticals firm, has made a significant stride in the US market with the launch of its groundbreaking autoimmune disease treatment, Zymfentra. [more…]
The arrival of Opill, the first over-the-counter oral contraceptive in the United States, marks a significant milestone in reproductive health accessibility. With a manufacturer’s suggested [more…]
Viking Therapeutics surged approximately 80% on Tuesday following the announcement of promising results from its mid-stage trial of an experimental weight loss drug. The drug, [more…]
Eisai plans to introduce its groundbreaking Alzheimer’s drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis [more…]
In a monumental stride forward in medical science, the U.S. Food and Drug Administration (FDA) has granted approval for the first gene-editing treatment for sickle [more…]
In a groundbreaking development, the Food and Drug Administration (FDA) has granted approval to Eli Lilly’s blockbuster drug, tirzepatide, for the treatment of obesity in [more…]
Novo Nordisk, a global pharmaceutical company known for its innovative treatments in diabetes care and obesity management, recently announced an encouraging development regarding the accessibility [more…]
In a growing health crisis, a multistate salmonella outbreak has swept across 22 U.S. states, resulting in at least 73 reported cases and 15 hospitalizations, [more…]